Product NDC: | 0832-0111 |
Proprietary Name: | Amantadine Hydrochloride |
Non Proprietary Name: | amantadine hydrochloride |
Active Ingredient(s): | 100 mg/1 & nbsp; amantadine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0832-0111 |
Labeler Name: | Upsher-Smith Laboratories, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076186 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111215 |
Package NDC: | 0832-0111-00 |
Package Description: | 100 TABLET in 1 BOTTLE (0832-0111-00) |
NDC Code | 0832-0111-00 |
Proprietary Name | Amantadine Hydrochloride |
Package Description | 100 TABLET in 1 BOTTLE (0832-0111-00) |
Product NDC | 0832-0111 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | amantadine hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20111215 |
Marketing Category Name | ANDA |
Labeler Name | Upsher-Smith Laboratories, Inc |
Substance Name | AMANTADINE HYDROCHLORIDE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] |